Skip to main content
Top
Published in: Trials 1/2024

Open Access 01-12-2024 | Mood Disorders | Study protocol

An e-mental health intervention to reduce depression symptoms in individuals with obesity: study protocol for the randomized, controlled, two-armed, confirmatory LightMood trial

Authors: Dilara Kocol, Sheila Geiger, Adam Schweda, Jil Beckord, Theresa Schadendorf, Christoph Jansen, Anita Robitzsch, Eva-Maria Skoda, Martin Teufel, Alexander Bäuerle

Published in: Trials | Issue 1/2024

Login to get access

Abstract

Background

Patients with obesity often experience psychological distress, specifically depression symptoms. Due to various barriers, such as limitations of healthcare offers, digital interventions, for example medical apps, can provide a suitable approach to support affected people. In the envisaged prospective randomized controlled trial, we aim to examine the efficacy of the LightMood intervention. The LightMood intervention is a manualized and user-centered, digital intervention for patients with obesity, with a duration of 4 months, which contains elements of cognitive behavioral therapy and mindfulness-based and skills-based exercises. We expect the LightMood intervention to be superior to treatment as usual (TAU) in terms of reducing depression symptoms.

Methods

The trial incorporates four distinct measurement time points: the baseline assessment, the post-treatment assessment, and 1- and 3-month follow-up assessments. Furthermore, we implemented in-treatment assessments for both groups. Participants will be randomized into two groups (LightMood intervention vs TAU). The aim is to include 128 participants (64 per group) in the study. Inclusion criteria are patients who are obese, at least 18 years old, with a private Internet access, and with adequate digital literacy and show depression symptoms (PHQ ≥ 10). Exclusion criteria are weekly outpatient individual psychotherapy, obesity surgery within the last year or planned within the next 7 months, no private Internet access, and the prescription of a new psychotropic drug within the last 2 weeks. The primary outcome is the post-assessment reduction in depression symptoms. Secondary outcomes will include the improvement in self-efficacy, quality of life, mindfulness, reduction in eating disorder symptoms, and body mass index (BMI). Furthermore, we expect a positive development of depression symptoms throughout the different time points (T1, T2, and T3) in patients with obesity.

Discussion

LightMood is an evidence-based, efficient, low-threshold online intervention that aims to reduce depression symptoms in people with obesity. Online interventions could offer a promising alternative to conventional face-to-face therapy. The primary objective of the current study is to add essential insight into the feasibility, efficacy, effectiveness, and acceptance of e-mental health interventions for people with obesity and depression symptoms.

Trial registration

German Clinical Trial Register (DRKS), DRKS00029219. Registered on May 19, 2023
Appendix
Available only for authorised users
Literature
12.
15.
go back to reference Schorr EN, Gepner AD, Dolansky MA, Forman DE, Park LG, Petersen KS, et al. American heart association cardiovascular disease in older populations committee of the council on clinical cardiology and council on cardiovascular and stroke nursing; council on arteriosclerosis, thrombosis and vascular biology; and council on lifestyle and cardiometabolic health. harnessing mobile health technology for secondary cardiovascular disease prevention in older adults: a scientific statement from the american heart association. Circ Cardiovasc Qual Outcomes. 2021;14(5):e000103. https://doi.org/10.1161/HCQ.0000000000000103.CrossRefPubMed Schorr EN, Gepner AD, Dolansky MA, Forman DE, Park LG, Petersen KS, et al. American heart association cardiovascular disease in older populations committee of the council on clinical cardiology and council on cardiovascular and stroke nursing; council on arteriosclerosis, thrombosis and vascular biology; and council on lifestyle and cardiometabolic health. harnessing mobile health technology for secondary cardiovascular disease prevention in older adults: a scientific statement from the american heart association. Circ Cardiovasc Qual Outcomes. 2021;14(5):e000103. https://​doi.​org/​10.​1161/​HCQ.​0000000000000103​.CrossRefPubMed
24.
go back to reference Schmitt A. German version of the Center for Epidemiologic Studies Depression Scale Revised (CESD-R); 2016. Schmitt A. German version of the Center for Epidemiologic Studies Depression Scale Revised (CESD-R); 2016.
25.
go back to reference Eaton WW, Smith C, Ybarra M, Muntaner C, Tien A. Center for Epidemiologic Studies Depression Scale: review and revision (CESD and CESD-R); 2004. Eaton WW, Smith C, Ybarra M, Muntaner C, Tien A. Center for Epidemiologic Studies Depression Scale: review and revision (CESD and CESD-R); 2004.
26.
go back to reference Van Dam NT, Earleywine M. Validation of the Center for Epidemiologic Studies Depression Scale—Revised (CESD-R): Pragmatic depression assessment in the general population. Psyc Res. 2011;186:128–32.CrossRef Van Dam NT, Earleywine M. Validation of the Center for Epidemiologic Studies Depression Scale—Revised (CESD-R): Pragmatic depression assessment in the general population. Psyc Res. 2011;186:128–32.CrossRef
27.
go back to reference Schwarzer R, Jerusalem M. Generalized Self-Efficacy scale. In: Weinman J, Wright S, Johnston M, editors. Measures in health psychology: A user’s portfolio. Causal and control beliefs. Windsor, England: NFER-NELSON; 1995. p. 35–7. Schwarzer R, Jerusalem M. Generalized Self-Efficacy scale. In: Weinman J, Wright S, Johnston M, editors. Measures in health psychology: A user’s portfolio. Causal and control beliefs. Windsor, England: NFER-NELSON; 1995. p. 35–7.
29.
go back to reference Buchheld N, Walach H. Achtsamkeit in Vipassana-Meditation und Psychotherapie: Die Entwicklung des "Freiburger Fragebogens zur Achtsamkeit." Zeitschrift Fur Klinische Psychologie Psychiatrie Und Psychotherapie; 2002. Buchheld N, Walach H. Achtsamkeit in Vipassana-Meditation und Psychotherapie: Die Entwicklung des "Freiburger Fragebogens zur Achtsamkeit." Zeitschrift Fur Klinische Psychologie Psychiatrie Und Psychotherapie; 2002.
30.
go back to reference Thiel A, Jacobi C, Horstmann S, Paul T, Nutzinger DO, Schüßler G. Eine deutschsprachige Version des Eating Disorder Inventory EDI-2. [German translation of the Eating Disorder Inventory EDI-2.]. Psychother Psychosom Med Psychol. 1997;47(9-10):365–76.PubMed Thiel A, Jacobi C, Horstmann S, Paul T, Nutzinger DO, Schüßler G. Eine deutschsprachige Version des Eating Disorder Inventory EDI-2. [German translation of the Eating Disorder Inventory EDI-2.]. Psychother Psychosom Med Psychol. 1997;47(9-10):365–76.PubMed
31.
go back to reference Hilbert A, Tuschen-Caffier B. Eating Disorder Examination: Deutschsprachige Übersetzung. 2nd ed. Tübingen: dgvt-Verlag; 2016. Hilbert A, Tuschen-Caffier B. Eating Disorder Examination: Deutschsprachige Übersetzung. 2nd ed. Tübingen: dgvt-Verlag; 2016.
34.
go back to reference Brooke J. SUS: A quick and dirty usability scale. Ind: Usability Eval; 1995. p. 189. Brooke J. SUS: A quick and dirty usability scale. Ind: Usability Eval; 1995. p. 189.
35.
go back to reference Venkatesh V, Morris MG, Davis GB, Davis FD. User acceptance of information technology: Toward a unified view. MIS Quarterly; 2003. p. 425–78. Venkatesh V, Morris MG, Davis GB, Davis FD. User acceptance of information technology: Toward a unified view. MIS Quarterly; 2003. p. 425–78.
39.
go back to reference Walters SJ, Jacques RM, dos Anjos Henriques-Cadby IB, Candlish J, Totton N, Xian MTS. Sample size estimation for randomised controlled trials with repeated assessment of patient-reported outcomes: what correlation between baseline and follow-up outcomes should we assume? Trials. 2019;20(1) https://doi.org/10.1186/s13063-019-3671-2. Walters SJ, Jacques RM, dos Anjos Henriques-Cadby IB, Candlish J, Totton N, Xian MTS. Sample size estimation for randomised controlled trials with repeated assessment of patient-reported outcomes: what correlation between baseline and follow-up outcomes should we assume? Trials. 2019;20(1) https://​doi.​org/​10.​1186/​s13063-019-3671-2.
Metadata
Title
An e-mental health intervention to reduce depression symptoms in individuals with obesity: study protocol for the randomized, controlled, two-armed, confirmatory LightMood trial
Authors
Dilara Kocol
Sheila Geiger
Adam Schweda
Jil Beckord
Theresa Schadendorf
Christoph Jansen
Anita Robitzsch
Eva-Maria Skoda
Martin Teufel
Alexander Bäuerle
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Trials / Issue 1/2024
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-024-07970-9

Other articles of this Issue 1/2024

Trials 1/2024 Go to the issue